Research library
Prepared by Pillar Research
KPV
Sources and editorial policyThe C-terminal tripeptide fragment of alpha-MSH (Lys-Pro-Val), studied for cellular anti-inflammatory signalling independent of melanocortin-receptor engagement.
Evidence limits
Reported mechanisms are model- and system-specific, including inflammatory-signalling studies in cell and animal models. This reference describes published research only and does not provide human-use, administration, or therapeutic guidance.
Sources
For current strength, AUD price, purity, batch COA and Australian dispatch, see KPV 10mg (Lys-Pro-Val Peptide) product specifications.